These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18706886)

  • 1. Mel-18 interacts with RanGAP1 and inhibits its sumoylation.
    Zhang J; Sarge KD
    Biochem Biophys Res Commun; 2008 Oct; 375(2):252-5. PubMed ID: 18706886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEL-18 interacts with HSF2 and the SUMO E2 UBC9 to inhibit HSF2 sumoylation.
    Zhang J; Goodson ML; Hong Y; Sarge KD
    J Biol Chem; 2008 Mar; 283(12):7464-9. PubMed ID: 18211895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative allosteric mechanisms can regulate the substrate and E2 in SUMO conjugation.
    Karaca E; Tozluoğlu M; Nussinov R; Haliloğlu T
    J Mol Biol; 2011 Mar; 406(4):620-30. PubMed ID: 21216249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The RanBP2/RanGAP1*SUMO1/Ubc9 complex is a multisubunit SUMO E3 ligase.
    Werner A; Flotho A; Melchior F
    Mol Cell; 2012 May; 46(3):287-98. PubMed ID: 22464730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection from isopeptidase-mediated deconjugation regulates paralog-selective sumoylation of RanGAP1.
    Zhu S; Goeres J; Sixt KM; Békés M; Zhang XD; Salvesen GS; Matunis MJ
    Mol Cell; 2009 Mar; 33(5):570-80. PubMed ID: 19285941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RanBP2/RanGAP1*SUMO1/Ubc9 complex: a multisubunit E3 ligase at the intersection of sumoylation and the RanGTPase cycle.
    Flotho A; Werner A
    Nucleus; 2012; 3(5):429-32. PubMed ID: 22925898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconstitution of the Recombinant RanBP2 SUMO E3 Ligase Complex.
    Ritterhoff T; Das H; Hao Y; Sakin V; Flotho A; Werner A; Melchior F
    Methods Mol Biol; 2016; 1475():41-54. PubMed ID: 27631796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing.
    Ivanov AV; Peng H; Yurchenko V; Yap KL; Negorev DG; Schultz DC; Psulkowski E; Fredericks WJ; White DE; Maul GG; Sadofsky MJ; Zhou MM; Rauscher FJ
    Mol Cell; 2007 Dec; 28(5):823-37. PubMed ID: 18082607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of DNA binding by differential sumoylation of heat shock factors.
    Anckar J; Hietakangas V; Denessiouk K; Thiele DJ; Johnson MS; Sistonen L
    Mol Cell Biol; 2006 Feb; 26(3):955-64. PubMed ID: 16428449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PCGF2 negatively regulates arsenic trioxide-induced PML-RARA protein degradation via UBE2I inhibition in NB4 cells.
    Jo S; Lee YL; Kim S; Lee H; Chung H
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1499-509. PubMed ID: 27030546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
    Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
    J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleolar and spindle-associated protein 1 (NUSAP1) interacts with a SUMO E3 ligase complex during chromosome segregation.
    Mills CA; Suzuki A; Arceci A; Mo JY; Duncan A; Salmon ED; Emanuele MJ
    J Biol Chem; 2017 Oct; 292(42):17178-17189. PubMed ID: 28900032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical characterization of SUMO-conjugating enzymes by in vitro sumoylation assays.
    Eisenhardt N; Ilic D; Nagamalleswari E; Pichler A
    Methods Enzymol; 2019; 618():167-185. PubMed ID: 30850051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant reconstitution of sumoylation reactions in vitro.
    Flotho A; Werner A; Winter T; Frank AS; Ehret H; Melchior F
    Methods Mol Biol; 2012; 832():93-110. PubMed ID: 22350878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex.
    Reverter D; Lima CD
    Nature; 2005 Jun; 435(7042):687-92. PubMed ID: 15931224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and dynamic independence of isopeptide-linked RanGAP1 and SUMO-1.
    Macauley MS; Errington WJ; Okon M; Schärpf M; Mackereth CD; Schulman BA; McIntosh LP
    J Biol Chem; 2004 Nov; 279(47):49131-7. PubMed ID: 15355965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The polycomb protein Pc2 is a SUMO E3.
    Kagey MH; Melhuish TA; Wotton D
    Cell; 2003 Apr; 113(1):127-37. PubMed ID: 12679040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubc9p and the conjugation of SUMO-1 to RanGAP1 and RanBP2.
    Saitoh H; Sparrow DB; Shiomi T; Pu RT; Nishimoto T; Mohun TJ; Dasso M
    Curr Biol; 1998 Jan; 8(2):121-4. PubMed ID: 9427648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sumoylation of the transcriptional intermediary factor 1beta (TIF1beta), the Co-repressor of the KRAB Multifinger proteins, is required for its transcriptional activity and is modulated by the KRAB domain.
    Mascle XH; Germain-Desprez D; Huynh P; Estephan P; Aubry M
    J Biol Chem; 2007 Apr; 282(14):10190-202. PubMed ID: 17298944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ SUMOylation analysis reveals a modulatory role of RanBP2 in the nuclear rim and PML bodies.
    Saitoh N; Uchimura Y; Tachibana T; Sugahara S; Saitoh H; Nakao M
    Exp Cell Res; 2006 May; 312(8):1418-30. PubMed ID: 16688858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.